Sign inJoin waitlistJoin the waitlist

DW

David Weng

Physician · Maryland Oncology Hematology Pa

Credentials: · · · · · ·

History

Maryland Oncology Hematology Pa
2020–Present

Medical Oncology
1995–1997
Internal Medicine
1992–1995
Johns Hopkins Univ Sch of Med
1988–1992

Research

Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models
Molecular Cancer Therapeutics · 2014 · 151 citations
Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells
The Journal of Immunology · 1997 · 151 citations
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Molecular Cancer Therapeutics · 2015 · 112 citations

PC
Peter Cohen
4 papers
Brian Czerniecki
3 papers
JC
Joseph Crowe
3 papers
PR
Pedro Escobar Rodriguez
3 papers · 3 as a fellow
RG
Ronald Gress
3 papers
Barry Meisenberg
2 papers
David Hicks
2 papers
GP
Gregory Plautz
2 papers
Hope Rugo
2 papers
Alex Adjei
1 paper
AA
Andrea Abati
1 paper
Anthony Elias
1 paper

Clinical trials

Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Daehwa Pharmaceutical Co., Ltd.
2018–2022